How do you develop therapeutics for unknown viruses, given there will not be time to develop a vaccine after it appears?
The answer could be in a new class of antiviral drugs that should do something seemingly impossible: work against a wide range of existing viruses and also be effective against viruses that have not even evolved yet.
And just as important if not more so, it should be extremely difficult for any virus to become resistant to these drugs.
Click here to read all about this important work.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment